Cargando…

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related death worldwide. Even early-stage patients might encounter disease recurrence with relative high risk. Effective postoperative therapy is based on an accurate assessment of treatment failure after surgery. The aim of this study is to construct a dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ching-Feng, Fu, Jui-Ying, Yeh, Chi-Ju, Liu, Yun-Hen, Hsieh, Ming-Ju, Wu, Yi-Cheng, Wu, Ching-Yang, Tsai, Ying-Huang, Chou, Wen-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616676/ https://www.ncbi.nlm.nih.gov/pubmed/26266381 http://dx.doi.org/10.1097/MD.0000000000001337

Ejemplares similares

Prognostic Value of Metastatic N1 Lymph Node Ratio and Angiolymphatic Invasion in Patients With Pathologic Stage IIA Non-Small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2014)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Deltoid Branch of Thoracoacromial Vein: A Safe Alternative Entry Vessel for Intravenous Port Implantation
por: Su, Ta-Wei, et al.
Publicado: (2015)

Predictive Value of (18)F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer
por: Ko, Kai-Hsiung, et al.
Publicado: (2015)

Risk factors for relapse of resectable pathologic N2 non small lung cancer and prediction model for time-to-progression
por: Wen, Chih-Tsung, et al.
Publicado: (2017)

Surgical result in non small cell lung cancer patients presenting with ground glass opacity predominant lesion less than 2 cm: Anatomic versus wedge resection
por: Wu, Ching-Feng, et al.
Publicado: (2021)

The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations
por: Hung, Ming-Szu, et al.
Publicado: (2016)

Factors Associated With False-Negative Endoscopic Biopsy Results After Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
por: Chao, Yin-Kai, et al.
Publicado: (2015)

Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis
por: Chen, Po-Huang, et al.
Publicado: (2021)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection
por: Fu, Jui-Ying, et al.
Publicado: (2018)

Correction: Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection
por: Fu, Jui-Ying, et al.
Publicado: (2019)

Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial
por: Tai, Cheng-Jeng, et al.
Publicado: (2015)

Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy
por: Chao, Yin-Kai, et al.
Publicado: (2015)

Possible pathways used to predict different stages of lung adenocarcinoma
por: Chen, Xiaodong, et al.
Publicado: (2017)

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer
por: Li, Can, et al.
Publicado: (2020)

Recurrence, death risk, and related factors in patients with stage 0 colorectal cancer: A nationwide population-based study
por: Hsieh, Ming-Hao, et al.
Publicado: (2020)

Comparison of different automated lesion delineation methods for metabolic tumor volume of (18)F-FDG PET/CT in patients with stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study
por: Yang, You-Rong, et al.
Publicado: (2021)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial
por: Wu, Ching-Yang, et al.
Publicado: (2020)

A recurrence-free survivor with chemotherapy-refractory small cell lung cancer after pneumonectomy: A case report and review of the literature
por: Pan, Yong, et al.
Publicado: (2017)

Long-Term Results of a Standard Algorithm for Intravenous Port Implantation
por: Wu, Ching-Feng, et al.
Publicado: (2021)

Efficacy of short-term nivolumab treatment in a Chinese patient with relapsed advanced-stage lung squamous cell carcinoma: A case report
por: Pi, Guoliang, et al.
Publicado: (2016)

Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report
por: Liu, Liang, et al.
Publicado: (2021)

Cancer Risk in HBV Patients With Statin and Metformin Use: A Population-Based Cohort Study
por: Chen, Chang-I., et al.
Publicado: (2015)

Unusual axillary metastasis of recurrent nasopharyngeal cancer: A case report
por: Kuo, Deng-Yu, et al.
Publicado: (2017)

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly
por: Wang, Peng, et al.
Publicado: (2016)

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
por: Hisakane, Kakeru, et al.
Publicado: (2017)

Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report
por: Hou, Tien-Chi, et al.
Publicado: (2020)

Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma
por: Isaka, Tetsuya, et al.
Publicado: (2015)

Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients
por: Wang, Kai, et al.
Publicado: (2015)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study
por: Jin, Jia-Nan, et al.
Publicado: (2022)

Mining prognostic factors of extensive-stage small-cell lung cancer patients using nomogram model
por: Gao, Hongxiang, et al.
Publicado: (2020)

Why recurrence was initially suspected during colorectal cancer postoperative surveillance?: A retrospective analysis
por: Hung, Hsinyuan, et al.
Publicado: (2020)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report
por: Ju, Yanxin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_13i60k33ooo2rb2dctkkr4r14o